Merck & Co will help make rival Johnson & Johnson's single-shot Covid-19 vaccine in a partnership set to be announced on Tuesday by US President Joe Biden, a White House official said. J&J's ...

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...

Innovative technology represents a breakthrough scientific achievement for one of the most common feline infectious diseases RAHWAY, N.J., September 24, 2024--(BUSINESS WIRE)--Merck Animal Health ...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...

RAHWAY, N.J. - Merck Animal Health, a division of Merck & Co., Inc. (NYSE:MRK), has announced the release of a new vaccine, NOBIVAC NXT FeLV, to protect cats against feline leukemia virus (FeLV).

The underlying S-TIR vaccine technology has been validated by both S-Target’s deal with Merck’s Allergopharma ... companion animals such as cats and dogs,” added Himmler.

It’s estimated that over 150,000 adults are hospitalized from pneumococcal pneumonia each year in the U.S. Merck has been at the forefront of pneumococcal disease prevention through vaccination ...

often simply referred to as Merck, is a global pharmaceutical giant that develops, manufactures, and sells prescription medicines, vaccines, and animal health products. At its core, Merck is in ...

The agreement grants Merck the option to license Evaxion’s preclinical vaccine candidates EVX-B2 and EVX-B3. Evaxion also granted Merck an option to license preclinical vaccine candidates EVX-B2 ...

Merck (NYSE:MRK) announced Wednesday that its 21-valent pneumococcal vaccine, Capvaxive, approved in the U.S. to prevent pneumonia, generated positive immune responses in a Phase 3 trial for ...

Merck & Co., Inc. (NYSE:MRK) is a U.S.-based pharmaceutical company that focuses on producing vaccines and providing hospital care services. Its top-selling cancer drug, Keytruda, is a standout ...

Merck (NYSE: MRK), known as MSD outside of the ... the continued impact of its increasingly broad and diverse vaccines and infectious disease portfolio and the potential of its innovative pipeline ...